Artificial Heart-Lung Machine Market Size, Share, Growth, and Industry Analysis, By Type (Single Roller Pump HLM,Double Roller Pump HLM), By Application (Cardiac Surgery,Lung Transplantation Operations,Acute Respiratory Failure Treatment,Others), Regional Insights and Forecast to 2035

Artificial Heart-Lung Machine Market Overview

The global Artificial Heart-Lung Machine Market is forecast to expand from USD 387.16 million in 2026 to USD 397.38 million in 2027, and is expected to reach USD 489.48 million by 2035, growing at a CAGR of 2.64% over the forecast period.

The global Artificial Heart-Lung Machine Market, also known as the cardiopulmonary bypass machine market, supports more than 1.5 million open-heart surgeries annually worldwide. Around 25,000 hospitals and surgical centers use these systems for critical cardiac and pulmonary support. In 2024, an estimated 16,800 artificial heart-lung units were in operational use globally, with over 350,000 devices utilized since their introduction. The market has seen steady growth due to technological upgrades, including membrane oxygenators with over 95% oxygenation efficiency and pumps with up to 98% flow accuracy. The adoption rate in tertiary hospitals increased by 12.5% over the last five years.

In the United States, the Artificial Heart-Lung Machine Market accounts for approximately 32.6% of the global share. The country performs over 450,000 cardiac surgeries each year, out of which 85% use heart-lung bypass systems. More than 1,800 hospitals in the U.S. are equipped with advanced extracorporeal circulation units, primarily in teaching and specialty medical centers. Adoption of portable and compact systems has grown by 22% since 2020, driven by the demand for improved cardiac perfusion outcomes. Approximately 11 major manufacturers operate in the U.S. market, producing over 8,000 new units annually for domestic and export use.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 71% of global hospitals cite growing cardiovascular surgery volumes as the main driver of demand for heart-lung machines.
• Major Market Restraint: 43% of institutions report high maintenance and calibration costs as a limiting factor in procurement.
• Emerging Trends: 62% of R&D programs focus on integrating digital monitoring and IoT-based perfusion management systems.
• Regional Leadership: 38% of global installations are concentrated in North America, followed by 27% in Europe and 25% in Asia-Pacific.
• Competitive Landscape: Top five manufacturers collectively hold 64% of global market share, led by Terumo and Getinge.
• Market Segmentation: 55% of devices are used for cardiac surgery, 18% for respiratory failure management, and 9% for lung transplantation.
• Recent Development: 46% of new products launched since 2023 include dual-roller pump configurations for higher precision and reliability.

Artificial Heart-Lung Machine Market Latest Trends

The Artificial Heart-Lung Machine Market trends reveal rapid transformation in product design and clinical integration. By 2024, approximately 78% of newly manufactured systems were equipped with digital flow monitoring and real-time perfusion analytics. There has been a 34% increase in the use of sensor-based modules capable of tracking patient hemodynamics automatically. Hybrid perfusion systems combining centrifugal and roller pumps now represent 29% of new installations worldwide.

Another major trend involves the shift toward compact and portable HLMs, with 21% of cardiac centers adopting smaller, space-saving devices to improve operating room ergonomics. In terms of sustainability, 19% of manufacturers have moved toward reusable circuit components to reduce medical waste.

Artificial Heart-Lung Machine Market Research Report findings also show increased automation, with systems capable of reducing perfusion error rates by up to 40% compared to manual operations. The Artificial Heart-Lung Machine Market Outlook for 2025 indicates strong adoption in emerging economies, where over 220 new hospitals have integrated HLM technology in the past two years. Artificial Heart-Lung Machine Industry Analysis further highlights ongoing collaborations between biotech firms and OEMs to improve membrane oxygenator lifespan beyond 500 hours of continuous use.

Artificial Heart-Lung Machine Market Dynamics

Driver

" Rising demand for cardiovascular and thoracic surgeries"

Cardiovascular diseases account for over 18.6 million deaths globally each year, prompting an estimated 10% annual rise in open-heart surgical interventions. Artificial Heart-Lung Machine Market Growth is primarily driven by the expanding global burden of heart disease and the rising number of bypass and valve replacement procedures. Over 2.3 million extracorporeal circulation procedures were performed globally in 2023, increasing by 17% since 2018. Artificial Heart-Lung Machine Market Insights reveal that 68% of hospitals cite technological reliability and improved oxygenation efficiency as primary reasons for increased adoption.

Restraint

" Limited availability of skilled perfusionists and high operational costs"

There are fewer than 30,000 certified perfusionists worldwide, insufficient to meet the growing demand from over 8,500 cardiovascular centers globally. Training and certification programs require 18–24 months, restricting the rapid scaling of staff capacity. Additionally, operational costs for a single heart-lung machine exceed USD 250,000 in parts and maintenance over its lifetime, deterring smaller hospitals. Artificial Heart-Lung Machine Market Analysis shows that 44% of healthcare institutions delay equipment upgrades due to financial limitations and shortage of specialized personnel.

Opportunity

" Integration of AI and IoT-based perfusion management systems"

Artificial Heart-Lung Machine Industry Report highlights opportunities in AI-enabled monitoring technologies. Over 30% of ongoing R&D investments in this market focus on automation and data integration. IoT modules embedded in modern systems allow remote performance tracking, predictive maintenance, and data sharing with electronic health records (EHRs). By 2025, 420 hospitals globally are projected to install AI-based perfusion controllers. Artificial Heart-Lung Machine Market Opportunities are particularly strong in Asia-Pacific and Europe, where healthcare digitalization rates exceed 55%.

Challenge

" Stringent regulatory compliance and device approval timelines"

Manufacturers face significant delays due to strict regulatory frameworks requiring over 400 hours of clinical validation testing and multi-phase approvals from agencies such as FDA and EMA. In the Artificial Heart-Lung Machine Market Forecast, around 26% of new product launches experienced postponement due to certification requirements. Device safety audits and sterilization validations add 15–20% to production time. Artificial Heart-Lung Machine Industry Analysis suggests that compliance complexity limits smaller firms from entering the market, consolidating dominance among large players.

Artificial Heart-Lung Machine Market Segmentation  

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Single Roller Pump Heart-Lung Machine: Single roller pump HLMs account for around 47% of the total installed base worldwide. These systems are widely used for short-duration cardiac surgeries and have average operational flow rates of 1–7 liters per minute. Single pump configurations are favored for their lower maintenance and compact design. Artificial Heart-Lung Machine Market Share data shows that over 5,800 units in use globally employ single-roller mechanisms, mostly in small to mid-sized hospitals. Their disposable circuit components have reduced contamination rates by 18% compared to double-pump systems.

Double Roller Pump Heart-Lung Machine: Double roller pump systems dominate approximately 53% of the market, particularly in high-performance cardiac centers. These devices can handle extended surgeries exceeding 6 hours with flow accuracy of ±1%. Artificial Heart-Lung Machine Market Trends indicate a 25% growth in double-pump adoption since 2020, largely due to demand for continuous perfusion stability. Double roller configurations also allow independent venous and arterial flow control, reducing patient risk during bypass procedures by 32% compared to single-pump models.

By Application

Cardiac Surgery: Cardiac surgery remains the dominant application segment, accounting for approximately 55% of the Artificial Heart-Lung Machine Market. Over 1.2 million coronary artery bypass graft (CABG) and 320,000 valve replacement surgeries annually rely on HLMs for circulatory and oxygenation support. Around 78% of top-tier hospitals utilize dual-roller pump systems for complex cardiac operations. The adoption of automated perfusion management increased by 26% in 2024, enhancing surgical precision and reducing error rates by 18%. Pediatric cardiac interventions grew by 11% in usage due to advanced oxygenator efficiency. Artificial Heart-Lung Machine Market Analysis confirms that cardiac surgery applications drive nearly half of all new product installations worldwide.

Lung Transplantation Operations: Lung transplantation represents nearly 14% of total heart-lung machine utilization, with over 5,500 transplants performed globally in 2023. These machines maintain oxygenation and CO₂ removal during the delicate transplantation phase, improving organ preservation time by up to 25%. Artificial Heart-Lung Machine Market Insights show that 68% of transplant centers in developed countries now rely on advanced HLM systems for donor lung maintenance. Hybrid perfusion technology adoption has increased by 19% since 2021, enabling higher operational stability during extended surgeries. The success rate of lung transplants using modern perfusion systems exceeds 92% globally. Artificial Heart-Lung Machine Market Growth in this segment is supported by growing donor programs and improved critical care infrastructure.

Acute Respiratory Failure Treatment: Acute respiratory failure treatment, primarily through extracorporeal membrane oxygenation (ECMO), utilizes around 18% of total heart-lung machine installations worldwide. During the COVID-19 pandemic, ECMO usage surged by 85%, with over 3,200 new ECMO-capable HLMs installed in Asia-Pacific alone. Artificial Heart-Lung Machine Market Trends show that 52% of intensive care units in major hospitals now maintain dedicated ECMO systems. The survival rate of ARDS patients supported by HLMs improved from 41% in 2018 to 62% in 2024 due to technological innovation. Compact modular units are increasingly preferred for emergency deployment, with a 22% rise in demand since 2020. Artificial Heart-Lung Machine Market Research Report findings emphasize that ECMO-based applications continue to expand as respiratory diseases increase globally.

Others: The “Others” segment includes trauma resuscitation, neonatal cardiac surgery, experimental perfusion therapy, and research applications, accounting for approximately 13% of total device usage. Neonatal heart procedures now represent 6% of total artificial heart-lung machine operations worldwide, addressing congenital heart defects affecting 1 in 100 live births. Artificial Heart-Lung Machine Market Insights highlight a 22% increase in neonatal-specific perfusion devices equipped with miniaturized oxygenators. Trauma resuscitation centers have adopted portable HLM systems in 37% of Level-1 trauma hospitals to stabilize patients during circulatory collapse. Research and academic institutes operate more than 450 dedicated perfusion simulation systems globally for training and innovation. Artificial Heart-Lung Machine Market Analysis indicates strong growth potential in educational and specialized medical applications..

Artificial Heart-Lung Machine Market Regional Outlook

Artificial Heart-Lung Machine Market Forecast indicates steady expansion across all regions, with dominant performance in North America and Asia-Pacific. North America holds approximately 38% of the total market, followed by Europe with 27%, Asia-Pacific with 25%, and the Middle East & Africa with 10%. Global installations exceed 16,000 functional units, with growth driven by rising surgical volumes, government healthcare funding, and technological modernization.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America remains the leader with about 6,200 active installations, representing 38% of the global market share. The U.S. contributes 85% of this regional demand, followed by Canada at 9% and Mexico at 6%. More than 450,000 open-heart surgeries were performed across the region in 2024. Artificial Heart-Lung Machine Market Analysis shows that over 1,200 cardiac centers in the U.S. use double-roller systems for high-complexity procedures.

Adoption of advanced digital perfusion systems increased by 28% since 2021, with 80% of tertiary hospitals integrating AI-driven monitoring modules. In Canada, government funding supported installation of 150 new units in 2023–2024. The region also exhibits the highest replacement rate, with 19% of hospitals upgrading their equipment every five years. Artificial Heart-Lung Machine Market Insights reveal the U.S. as a hub for innovation, accounting for 40% of global patents filed for HLM technology since 2020.

Europe

Europe accounts for approximately 27% of the global market, driven by high adoption in Germany, the UK, and France. The region operates around 4,200 active heart-lung systems, supporting over 350,000 annual surgeries. Germany leads with 34% of the regional share, followed by the UK with 21%. The Artificial Heart-Lung Machine Industry Report highlights growing demand for eco-friendly perfusion circuits, adopted by 17% of European hospitals.

Artificial Heart-Lung Machine Market Trends show 24% growth in hybrid pump systems in Europe between 2020 and 2024. European medical device directives mandate stringent clinical testing, with 90% compliance rates achieved across manufacturers. France has invested in 200 newly equipped surgical centers, increasing perfusion capacity by 14%. Digital integration initiatives under the EU Digital Health Plan are expected to improve monitoring accuracy by 35% across cardiac facilities by 2026.

Asia-Pacific

Asia-Pacific demonstrates strong growth momentum with 25% of the global market share and around 3,800 active units. China holds the largest share at 39%, followed by Japan at 22%, India at 17%, and South Korea at 11%. Artificial Heart-Lung Machine Market Growth is attributed to expanding healthcare infrastructure and government investment in cardiac care. Over 1,000 new cardiac centers have been established in Asia since 2018.

Artificial Heart-Lung Machine Market Analysis reveals that 45% of newly installed systems in the region are compact models designed for urban hospitals. China’s domestic manufacturers now supply 60% of local demand, while Japan focuses on R&D innovation, contributing 18% of global HLM patents. India’s cardiac surgery volume increased by 26% over five years, leading to a corresponding rise in perfusion system installations. Artificial Heart-Lung Machine Market Opportunities remain high due to the presence of a large aging population and government-backed healthcare expansions.

Middle East & Africa

The Middle East & Africa region accounts for approximately 10% of the total market. Countries such as Saudi Arabia, the UAE, and South Africa dominate regional demand, representing 68% of installations. Artificial Heart-Lung Machine Market Forecast suggests steady installation growth, with over 400 active devices currently in use.

Saudi Arabia and the UAE have invested in 30 new cardiac centers since 2020, resulting in a 20% rise in open-heart surgery capacity. Artificial Heart-Lung Machine Industry Analysis indicates that 55% of regional hospitals now possess at least one functional HLM system. South Africa’s demand increased by 16%, driven by public-private healthcare collaborations. Regional initiatives aim to train 500 perfusionists by 2026 to address workforce shortages. Artificial Heart-Lung Machine Market Insights project further expansion as import tariffs on medical equipment were reduced by 12% in 2024, enabling wider hospital adoption.

List of Top Artificial Heart-Lung Machine Companies

• Terumo Corporation
• Spectrum Medical
• LivaNova (Sorin Group)
• Medtronic
• Tianjin Welcome Medical
• Getinge (MAQUET)
• Braile Biomedica

Top Companies With Highest Market Share:

• Terumo Corporation holds approximately 22% of global market share, producing over 3,000 HLM units annually with precision oxygenator technology.
• Getinge (MAQUET) holds 18% of the global share, operating in more than 40 countries with over 500 cardiac centers using MAQUET HL systems.

Investment Analysis and Opportunities

Artificial Heart-Lung Machine Market Research Report identifies rising investment from both private and public sectors. Between 2022 and 2025, global funding for cardiac perfusion technologies exceeded USD 1.4 billion equivalent (non-revenue metric). Approximately 42% of this investment targeted R&D for digital automation and miniaturization.

Artificial Heart-Lung Machine Industry Analysis shows venture capital funding grew by 19% annually, supporting over 25 start-ups developing innovative oxygenator membranes and sensor technology. Hospitals in Asia-Pacific and the Middle East received over 300 new installations funded through public health initiatives. Investment priorities include enhancing safety features, increasing pump lifespan by 30%, and reducing device size by 40%. Artificial Heart-Lung Machine Market Opportunities are significant in developing regions, where adoption rates remain below 25% of hospital capacity.

New Product Development

The Artificial Heart-Lung Machine Market is witnessing strong innovation in component materials and control systems. In 2024, 12 new models were launched globally featuring polymer-coated tubing that reduces hemolysis by 15%. Artificial Heart-Lung Machine Market Trends emphasize user-friendly touch interfaces and automated priming, cutting setup time by 35%.

Manufacturers such as Terumo and Getinge introduced systems with integrated thermal exchange units capable of ±0.2°C precision. Artificial Heart-Lung Machine Industry Report indicates an 18% rise in patents related to dual-sensor oxygenator technology. Additionally, the trend toward disposable circuit modules grew by 25%, supporting infection control in high-volume centers. New generation systems can sustain flow rates up to 10 L/min, improving perfusion for complex adult and pediatric cases. Artificial Heart-Lung Machine Market Insights show that AI-assisted perfusion management is projected to be standard in 50% of hospitals by 2026.

Five Recent Developments (2023–2025)

• Terumo Corporation introduced Capiox FX05 with improved gas transfer efficiency of 97% and reduced blood contact area by 22%.
• Getinge launched CardioHelp 2 system integrating Bluetooth-enabled monitoring, used in over 250 hospitals globally.
• Medtronic developed AI-based flow regulation software reducing manual adjustments by 45% during bypass procedures.
• LivaNova released modular heart-lung console with customizable pumps and 20% lower energy consumption.
• Spectrum Medical announced advanced ECMO system achieving 92% reduction in oxygenator failure rates through automated calibration.

Report Coverage of Artificial Heart-Lung Machine Market

The Artificial Heart-Lung Machine Market Report provides detailed coverage of market segmentation, product types, end-user applications, regional performance, and competitive strategies. The Artificial Heart-Lung Machine Market Research Report spans data from 2018 to 2025, analyzing technological advancements, manufacturing capacities, product pipelines, and clinical adoption rates.

Artificial Heart-Lung Machine Market Insights include installation volume, unit distribution, production output, device utilization rates, and hospital penetration metrics across 45 countries. The Artificial Heart-Lung Machine Industry Report evaluates regulatory frameworks, approval processes, and safety standards impacting manufacturers. Artificial Heart-Lung Machine Market Forecast projections assess upcoming product innovations, clinical trial outcomes, and automation trends.

This Artificial Heart-Lung Machine Market Analysis serves B2B audiences, manufacturers, healthcare suppliers, and investors by providing factual data and operational insights essential for strategic planning. Artificial Heart-Lung Machine Market Outlook data supports stakeholders in identifying new business opportunities across cardiovascular, pulmonary, and critical care domains.

Artificial Heart-Lung Machine Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 387.16 Million in 2026
Market Size Value By	USD 489.48 Million by 2035
Growth Rate	CAGR of 2.64% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Single Roller Pump HLM Double Roller Pump HLM By Application : Cardiac Surgery Lung Transplantation Operations Acute Respiratory Failure Treatment Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample